• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中度肾功能不全独立增加心脏骤停风险:一项基于社区的研究。

Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.

作者信息

Truyen Thien Tan Tri Tai, Uy-Evanado Audrey, Chugh Harpriya, Reinier Kyndaron, Charytan David M, Salvucci Angelo, Jui Jonathan, Chugh Sumeet S

机构信息

Center for Cardiac Arrest Prevention, Department of Cardiology Smidt Heart Institute, Cedars-Sinai Health System Los Angeles CA USA.

Nephrology Division, NYU Grossman School of Medicine New York NY USA.

出版信息

J Am Heart Assoc. 2025 Aug 5;14(15):e042307. doi: 10.1161/JAHA.125.042307. Epub 2025 Jul 29.

DOI:10.1161/JAHA.125.042307
PMID:40728166
Abstract

BACKGROUND

Moderate kidney dysfunction is independently associated with increased cardiovascular death. Sudden cardiac arrest (SCA) accounts for at least 25% of chronic kidney disease (CKD) death. This study aimed to evaluate the impact of moderate CKD on SCA risk.

METHODS

We conducted a case-control study within a community-based investigation of SCA in the Portland, Oregon, metropolitan area from February 1, 2002, to December 31, 2020. Analysis included individuals aged 40 to 75 years who experienced SCA (cases) and individuals with no history of SCA (controls), with creatinine levels measured before SCA/enrollment. Moderate CKD was defined by an estimated glomerular filtration rate of 30 to <60 mL/min per 1.73 m (2021 Chronic Kidney Disease Epidemiology Collaboration formula). A population-based SCA study in southern California was used for validation.

RESULTS

We compared 2068 SCA cases and 852 controls (mean ages, 61.4±8.5 and 62.7±8.0 years, respectively; men: 69.9% and 67.4%, respectively). SCA cases had more moderate CKD (17.7% versus 14.7%, <0.001) and lower estimated glomerular filtration rate (74.7 versus 80.9 mL/min per 1.73 m, <0.001) than controls. Multivariable regression demonstrated that moderate CKD was an independent risk factor for SCA (odds ratio, 1.32 [95% CI, 1.02-1.71]). Each 10 mL/min per 1.73 m estimated glomerular filtration rate drop to <90 increased SCA risk (odds ratio, 1.24 [95% CI, 1.18-1.31]). Similar findings were observed in the validation cohort (817 SCA and 3249 controls), where moderate CKD was associated with SCA (odds ratio, 1.54 [95% CI, 1.18-2.00]).

CONCLUSIONS

Moderate CKD is associated with an increased risk of SCA in the general population. Further research into the potential integration of moderate renal dysfunction into SCA risk stratification are warranted.

摘要

背景

中度肾功能不全与心血管死亡风险增加独立相关。心脏骤停(SCA)至少占慢性肾脏病(CKD)死亡的25%。本研究旨在评估中度CKD对SCA风险的影响。

方法

我们在2002年2月1日至2020年12月31日对俄勒冈州波特兰市大都市区进行的一项基于社区的SCA调查中开展了一项病例对照研究。分析纳入了年龄在40至75岁之间经历过SCA的个体(病例组)和无SCA病史的个体(对照组),并在SCA发生前/入组时测量了肌酐水平。中度CKD定义为估算肾小球滤过率为30至<60 mL/(min·1.73 m²)(采用2021年慢性肾脏病流行病学协作公式)。一项在南加州开展的基于人群的SCA研究用于验证。

结果

我们比较了2068例SCA病例和852例对照(平均年龄分别为61.4±8.5岁和62.7±8.0岁;男性分别占69.9%和67.4%)。与对照组相比,SCA病例中有更多的中度CKD(分别为17.7%和14.7%,P<0.001)且估算肾小球滤过率更低(分别为74.7和80.9 mL/(min·1.73 m²),P<0.001)。多变量回归显示,中度CKD是SCA的独立危险因素(比值比,1.32 [95%CI,1.02 - 1.71])。估算肾小球滤过率每下降10 mL/(min·1.73 m²)至<90 mL/(min·1.73 m²),SCA风险增加(比值比,1.24 [95%CI,1.18 - 1.31])。在验证队列(817例SCA和3249例对照)中观察到了类似结果,其中中度CKD与SCA相关(比值比,1.54 [95%CI,1.18 - 2.00])。

结论

中度CKD与普通人群中SCA风险增加相关。有必要进一步研究将中度肾功能不全潜在纳入SCA风险分层的可能性。

相似文献

1
Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.中度肾功能不全独立增加心脏骤停风险:一项基于社区的研究。
J Am Heart Assoc. 2025 Aug 5;14(15):e042307. doi: 10.1161/JAHA.125.042307. Epub 2025 Jul 29.
2
Moderate Kidney Dysfunction Independently Increases Sudden Cardiac Arrest Risk: A Community-Based Study.中度肾功能不全独立增加心脏骤停风险:一项基于社区的研究。
medRxiv. 2025 Mar 13:2025.03.12.25323871. doi: 10.1101/2025.03.12.25323871.
3
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
4
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.
5
Hospitalizations among adults with chronic kidney disease in the United States: A cohort study.美国慢性肾脏病成人患者的住院情况:一项队列研究。
PLoS Med. 2020 Dec 11;17(12):e1003470. doi: 10.1371/journal.pmed.1003470. eCollection 2020 Dec.
6
Allopurinol for the treatment of chronic kidney disease: a systematic review.别嘌醇治疗慢性肾脏病:一项系统评价
Health Technol Assess. 2014 Jun;18(40):1-77, v-vi. doi: 10.3310/hta18400.
7
Inflammatory and Cardiovascular Events in CKD: The Multi-Ethnic Study of Atherosclerosis (MESA).慢性肾脏病中的炎症与心血管事件:动脉粥样硬化多民族研究(MESA)
Am J Kidney Dis. 2025 May 15. doi: 10.1053/j.ajkd.2025.03.020.
8
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
9
Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.用于慢性肾病和糖尿病患者的胰高血糖素样肽1(GLP-1)受体激动剂。
Cochrane Database Syst Rev. 2025 Feb 18;2(2):CD015849. doi: 10.1002/14651858.CD015849.pub2.
10
Metformin for preventing the progression of chronic kidney disease.二甲双胍预防慢性肾脏病进展。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013414. doi: 10.1002/14651858.CD013414.pub2.